Submit Manuscript  

Article Details

CoMFA and CoMSIA Studies of 1,2-dihydropyridine Derivatives as Anticancer Agents

[ Vol. 8 , Issue. 3 ]


Ismail Salama, Mohamed A. O. Abdel-Fattah, Marwa S. Hany, Shaimaa A. El-Sharif, Mahmoud A. M. El-Naggar, Rasha M. H. Rashied, Gary A. Piazza and Ashraf H. Abadi   Pages 372 - 383 ( 12 )


Taking advantage of our in-house experimental data on 3-cyano-2-imino-1, 2-dihydropyridine and 3-cyano-2- oxo-1,2-dihydropyridine derivatives as inhibitors of the growth of the human HT-29 colon adenocarcinoma tumor cell line, we have established a highly significant CoMFA and CoMSIA models (q2 cv =0.70/0.639). The models were investigated to assure their stability and predictivity (r2 pred= 0.65/0.61) and successfully applied to design two new potential cell growth inhibitory agents with IC50s in the submicromolar range.


3D-QSAR, CoMFA/CoMSIA model, 3-cyano-2-imino-1, 2-dihydropyridine, 3-cyano-2-oxo-1, 2-dihydropyridine, antidepressant, angiogenesis, adenocarcinoma, dihydropyridine, adenocarcinoma, submicromolar


Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.

Read Full-Text article